Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · SALEM, MA · NPI 1528077666
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 476 | 147 |
| Amlodipine Besylate | Amlodipine Besylate | 380 | 115 |
| Lisinopril | Lisinopril | 257 | 73 |
| Omeprazole | Omeprazole | 247 | 81 |
| Simvastatin | Simvastatin | 245 | 77 |
| Metoprolol Succinate | Metoprolol Succinate | 206 | 71 |
| Eliquis | Apixaban | 181 | 39 |
| Metformin Hcl | Metformin Hcl | 179 | 60 |
| Gabapentin | Gabapentin | 156 | 42 |
| Levothyroxine Sodium | Levothyroxine Sodium | 154 | 44 |
| Lorazepam | Lorazepam | 142 | 50 |
| Losartan Potassium | Losartan Potassium | 141 | 41 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 134 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 130 | 37 |
| Clonazepam | Clonazepam | 123 | 23 |
| Famotidine | Famotidine | 118 | 31 |
| Oxycodone Hcl | Oxycodone Hcl | 116 | 19 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 115 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 107 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 102 | 34 |
| Sertraline Hcl | Sertraline Hcl | 101 | 28 |
| Alprazolam | Alprazolam | 100 | 20 |
| Pantoprazole Sodium | Pantoprazole Sodium | 100 | 33 |
| Trazodone Hcl | Trazodone Hcl | 99 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 86 | 37 |
| Metformin Hcl Er | Metformin Hcl | 81 | 25 |
| Atenolol | Atenolol | 79 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 79 | 17 |
| Mirtazapine | Mirtazapine | 78 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 74 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 72 | 12 |
| Tramadol Hcl | Tramadol Hcl | 67 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 65 | 19 |
| Furosemide | Furosemide | 59 | 22 |
| Allopurinol | Allopurinol | 57 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 57 | 20 |
| Ezetimibe | Ezetimibe | 56 | 21 |
| Ozempic | Semaglutide | 51 | suppressed |
| Prednisone | Prednisone | 51 | 33 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 50 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 50 | suppressed |
| Glipizide Er | Glipizide | 49 | 14 |
| Labetalol Hcl | Labetalol Hcl | 45 | suppressed |
| Jardiance | Empagliflozin | 43 | 14 |
| Baclofen | Baclofen | 42 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 42 | 22 |
| Finasteride | Finasteride | 41 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 39 | 12 |
| Pregabalin | Pregabalin | 38 | suppressed |
| Levetiracetam | Levetiracetam | 36 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 36 | 13 |
| Carvedilol | Carvedilol | 35 | suppressed |
| Potassium Chloride | Potassium Chloride | 35 | 13 |
| Valacyclovir | Valacyclovir Hcl | 35 | 11 |
| Torsemide | Torsemide | 34 | 11 |
| Montelukast Sodium | Montelukast Sodium | 33 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 32 | suppressed |
| Ibuprofen | Ibuprofen | 32 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 26 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 26 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | 11 |
| Celecoxib | Celecoxib | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 25 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Ramipril | Ramipril | 25 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 23 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 23 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 23 | suppressed |
| Xarelto | Rivaroxaban | 23 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | suppressed |
| Risperidone | Risperidone | 22 | suppressed |
| Methadone Hcl | Methadone Hcl | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Meloxicam | Meloxicam | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Spironolactone | Spironolactone | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | 11 |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Ofloxacin | Ofloxacin | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Tegretol | Carbamazepine | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 12 | suppressed |
| Demeclocycline Hcl | Demeclocycline Hcl | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Sulindac | Sulindac | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error